KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis

被引：5
|
作者：
Goris, An [1 ]
Dobosi, Rita [1 ]
Boonen, Steven [2 ,3 ]
Nagels, Guy [4 ]
Dubois, Benedicte [1 ]
机构：
[1] Katholieke Univ Leuven, Sect Expt Neurol, Lab Neuroimmunol, B-3000 Louvain, Belgium
[2] Univ Leuven, Ctr Metab Bone Dis, B-3000 Louvain, Belgium
[3] Univ Leuven, Div Geriatr Med, B-3000 Louvain, Belgium
[4] Natl MS Ctr Melsbroek, B-1820 Melsbroek, Belgium
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2009年 / 210卷 / 1-2期
关键词：
Multiple sclerosis; Natural killer cells; KIR2DL4; Association; Genetics; Autoimmunity; NATURAL-KILLER-CELLS; INTERLEUKIN-7; RECEPTOR; NK CELLS; ALLELES; RISK;
D O I：
10.1016/j.jneuroim.2009.03.001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Several lines of evidence implicate CD56(bright) NK cells in the pathogenesis of multiple sclerosis (MS). This proposed immunoregulatory pathway involves already established susceptibility genes such as interleukin-2 receptor alpha (IL2RA) and interleukin-7 receptor (IL7R). We therefore investigated the CD56(bright) NK cell effector molecule KIR2DL4 for its involvement in genetic susceptibility to MS in a study population of 763 cases and 967 controls. Whereas 26% of the study population has a genotype corresponding to a lack of any functional membrane-bound form of the molecule, no association of the KIR2DL4 transmembrane alleles with susceptibility to MS was observed. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [1] KIR2DL4 (CD158d). an activation receptor for HLA-G
    Rajagopalan, Sumati
    Long, Eric O.
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [2] KIR2DL4 (CD158d) genotype influences expression and function in NK cells
    Goodridge, JP
    Witt, CS
    Christiansen, FT
    Warren, HS
    JOURNAL OF IMMUNOLOGY, 2003, 171 (04): : 1768 - 1774
  • [3] KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential
    Faure, M
    Long, EO
    JOURNAL OF IMMUNOLOGY, 2002, 168 (12): : 6208 - 6214
  • [4] Endosomal Signaling and a Novel Pathway Defined by the Natural Killer Receptor KIR2DL4 (CD158d)
    Rajagopalan, Sumati
    TRAFFIC, 2010, 11 (11) : 1381 - 1390
  • [5] Genetic polymorphism of KIR2DL4 (CD158d), a putative NK cell receptor for HLA-G, does not influence susceptibility to asthma
    Le Page, M. E. L.
    Goodridge, J. P.
    Zhang, G.
    Holt, P. G.
    Sly, P.
    Witt, C. S.
    TISSUE ANTIGENS, 2013, 82 (04): : 276 - 279
  • [6] Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells
    Goodridge, Jodie P.
    Lathbury, Louise J.
    Steiner, Noriko K.
    Shulse, Christine N.
    Pullikotil, Philomena
    Seidah, Nabil G.
    Hurley, Carolyn K.
    Christiansen, Frank T.
    Witt, Campbell S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (01) : 199 - 211
  • [7] Cutting edge:: induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells
    Rajagopalan, S
    Fu, J
    Long, EO
    JOURNAL OF IMMUNOLOGY, 2001, 167 (04): : 1877 - 1881
  • [8] KIR2DL4 (CD158d) is an IL-2 regulated NK cell receptor that triggers strong IFN-gamma production despite a potent cytoplasmic inhibitory domain
    Campbell, KS
    Yusa, S
    Catina, TL
    Kikuchi-Maki, A
    FASEB JOURNAL, 2003, 17 (07): : C83 - C83
  • [9] The elucidation of KIR2DL4 gene polymorphism
    Schellekens, Jennifer
    Tilanus, Marcel G. J.
    Rozemuller, Erik H.
    MOLECULAR IMMUNOLOGY, 2008, 45 (07) : 1900 - 1906
  • [10] Genetic polymorphism of KIR2DL4 in the Polish population
    Nowak, I.
    Barcz, E.
    Majorczyk, E.
    Malinowski, A.
    Wilczynski, J. R.
    Banasik, M.
    Motak-Pochrzest, H.
    Kusnierczyk, P.
    TISSUE ANTIGENS, 2015, 85 (06): : 450 - 457
12345